OmniStar Financial Group’s Medifast MED Stock Holding History

OmniStar Financial Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-31	Closed	-$2K	–	236
2020 Q1	$2K	Buy	+31	New	+$2.82K	﹤0.01%	311

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

OmniStar Financial Group's MED Position: Q2 2020 in Review

OmniStar Financial Group sold out of Medifast (MED) in Q2 2020, closing a stake of 31 shares — an estimated $2K sold.

OmniStar Financial Group first reported a position in MED in Q1 2020 and held it in 1 quarter. The position peaked at $2K in Q1 2020. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

OmniStar Financial Group reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
OmniStar Financial Group sold 31 Medifast shares in Q2 2020, an estimated $2K.
OmniStar Financial Group first reported a position in Medifast in Q1 2020 and held it in 1 quarter.
OmniStar Financial Group's Medifast position peaked at $2K in Q1 2020.
224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on OmniStar Financial Group's 13F filing for Q2 2020, filed 6 Jul 2020.